STAT November 6, 2024
Allison DeAngelis, Matthew Herper, Andrew Joseph, Jason Mast, Ed Silverman

Bausch + Lomb’s CEO is ‘optimistic,’ while Curie.Bio CEO says RFK Jr. is ‘scary’

With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are preparing for the shift to an administration with a complicated history.

Trump...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Putting Patients First by Extending the Reach of World-Class Care
Biotech startups are built on venture capital. Track funding rounds here.

Share This Article